R&D Centre Expands Bioavailability Enhancement and Formulation Capabilities

Merck Millipore, the life science division of Merck, has announced the opening of its new Research & Development Center for Formulation in Darmstadt, Germany. The Center for Formulation combines formulation, analytical and synthetic laboratories and a fully-equipped customer training centre in a single facility. It will accelerate growth of the company’s portfolio of technologies and products that overcome bioavailability and formulation challenges and will provide hands-on support to assist customers in their drug development.

“To better address the needs of our pharmaceutical customers, we are expanding our capabilities for bioavailability enhancement,” said Burghard Freiberg, Senior Vice President, Pharma Chemicals Solutions. “There is a clear market need for a comprehensive set of innovative products and technologies to support bioavailability enhancement. At our new Center for Formulation, we can help customers overcome formulation-related challenges, such as insufficient API performance due to poor solubility and lifecycle management developments, in a more effective and efficient manner.”

Expertise offered by Merck Millipore includes oral dosage formulation development and drug delivery systems. Core areas are inorganic carriers, solid dispersion formulation techniques and development of other excipients and excipient systems. Technologies include granulation, tabletting, film coating, direct compression and freeze drying. When requested by customers, formulated products can be analytically characterised in the new laboratory.  

Merck Millipore, +1 781 533 5336, pegeen.dossantos@emdmillipore.com, www.merckmillipore.com.